Europe's Q2 2026 early-stage tape: 116 rounds, split almost evenly between 56 Seed and 60 Series A

Asked:

“Find a list of all the startups headquartered in Europe that raised seed or series A funding in the last quarter. Exclude biotech or pharmaceutical startups from the report”

All qualifying companies found across scanned public sources — pan-European and country startup media, funding roundups and deal coverage — for the most recent completed quarter, Q2 2026 (April 1 – June 30). Amounts stay in their originally reported currency, so euro, dollar and pound figures sit side by side and are not directly comparable. Biotech and pharma are excluded; open-web coverage cannot prove absolute completeness.

116

qualifying startups found

Seed rounds

Series A rounds

Every round by headquarters country, Seed vs Series A

One square per startup, grouped by headquarters as precisely as the source reported it. Hover a square for the company and round.

Seed · Series A

Rounds by source publication month

Source publication month — when the round was published or indexed, not a funding-volume trend; roundup coverage can lag the announcement.

Four outsized Series A rounds anchor the quarter — Focused Energy's $240M (fusion, Germany, qubit.capital), Quobly's €115M (quantum, France, qubit.capital), Prem AI's $100M (private AI, Switzerland, thenextweb.com) and THEKER's $85M (robotics, Barcelona, brpx.com) — reported in three different currencies, so ranks are indicative only.

The United Kingdom leads on count with 24 rounds, ahead of Germany (14) and France (13); Spain follows with 9 including THEKER's record robotics round (brpx.com).

June dominates the tape: 67 of 116 rounds carry a June source date, versus 23 in April and 26 in May — a publication-date pattern, not necessarily a closing-date one (qubit.capital).

19 rounds are located only regionally — 8 as CEE, 8 simply as "European" and 3 as cross-border — preserved at the granularity the source gave (sesamers.com).

All 116 companies

Company	Stage	Amount (as reported)	Headquarters	Sector	Investors named	Source date	Source

Method: web-wide scan of pan-European and country startup media, funding roundups, tech publications and deal coverage; 116 rows, Q2 2026 (Apr 1 – Jun 30, screened by source publication/index date, not always the legal closing date). Only rounds explicitly labeled Seed or Series A, including extensions; pre-seed, later stages, venture funds, biotech and pharma excluded — health software, devices, diagnostics, agritech, foodtech and climate/fusion retained where not biotech or pharma. Amounts kept in original currency, no FX conversion. Blank cells mean the source did not resolve that field; corroborating-pages flags entries seen on more than one page. Open-web coverage cannot guarantee mathematical exhaustiveness — private or paywalled rounds may be absent.

This report was generated automatically by Keenable SELECT at a user's request, from publicly available web sources linked herein. Keenable does not review, verify, or endorse its contents and makes no representation as to accuracy, completeness, or timeliness; AI-based extraction may contain errors. Nothing in this report is investment, legal, financial, or other professional advice. All trademarks and referenced content remain the property of their respective owners; no affiliation or endorsement is implied. To report an error, rights concern, or request removal: legal@keenable.ai.